Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: Goodrx - The Real Truth

New Orleans man moves, thinks his new Walgreens will be calmer, then witnesses an ‘insurance-based psychological event’

“This is Tennessee Williams."

We Got This Covered

FTC Alleges a Telehealth Company Sent Users' Health Conditions to Ad Platforms After Promising Discretion

FTC Alleges a Telehealth Company Sent Users' Health Conditions to Ad Platforms After Promising Discretion

The FTC sued Hims and Hers over alleged sharing of sensitive health data with ad platforms. What the complaint alleges and how to check your own accounts.

Denied Coverage For Wegovy Or Zepbound? Here Is What The Latest Value Assessment Says About Price And Access

Denied Coverage For Wegovy Or Zepbound? Here Is What The Latest Value Assessment Says About Price And Access

Denied for Wegovy or Zepbound? A new value analysis explains why plans refuse coverage and what exceptions and appeals actually involve.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Why Your Pharmacy Can Charge Two Different Prices for the Same Prescription on the Same Day

You arrive at the pharmacy expecting to pay your usual $18 copay. Instead, the cashier tells you the prescription will cost $142. Before you walk...

Trump and Mark Cuban's Surprise TrumpRx Alliance Sends Big Pharma Reeling

Mark Cuban's unexpected partnership with Donald Trump on the TrumpRx expansion ignites political backlash, viral controversy, and fresh debate over US drug pricing.

International Business Times UK

GoodRx vs. CVS vs. Costco: Where Retirees Save the Most on Prescriptions

Retirees can save big on prescription drugs, but prices vary widely. Here’s how GoodRx, CVS and Costco compare on common medications.

Top 5 Best Customer Identity and Access Management (CIAM) Solutions in 2026

Compare the top 5 customer identity and access management (CIAM) platforms in 2026 to find the right fit for your product's authentication needs.

International Business Times

inkl

Read news from The Economist, FT, and more,
with one subscription

Trump Rx prescription drug site ‘not a solution’ for many patients, experts say

Trump Rx prescription drug site ‘not a solution’ for many patients, experts say

New website lists only limited number of medications – and many of them cost less in generic form elsewhere

The Guardian - US

Trump and Dr. Oz bring ‘As Seen on TV’ vibes to Rx coupon portal for cheap ‘fat drugs’

Trump and Dr. Oz bring ‘As Seen on TV’ vibes to Rx coupon portal for cheap ‘fat drugs’

ANALYSIS: The president’s latest gambit at health care affordability, TrumpRx, isn’t the panacea he promised for access to low-cost GLP-1 drugs like Wegovy, Ozempic and Mounjaro— but some experts tell Andrew Feinberg that the effort should not be dismissed

The Independent UK

Trump launches TrumpRx website promising ‘dramatic discounts’ on prescription drugs, but the fine print reveals a major catch

Trump launches TrumpRx website promising ‘dramatic discounts’ on prescription drugs, but the fine print reveals a major catch

Just GoodRx with his name slapped on?

We Got This Covered

Why “GoodRx” is No Longer Enough: The 2026 Drug Reclassifications You Weren’t Told About

Why “GoodRx” is No Longer Enough: The 2026 Drug Reclassifications You Weren’t Told About

For years, many of us treated GoodRx like a secret weapon. If a prescription was too expensive through insurance, we’d just pull up a coupon...

Pharmacy Discount Programs Are Shrinking at National Chains

Pharmacy Discount Programs Are Shrinking at National Chains

If you’ve relied on pharmacy discount cards like GoodRx, SingleCare, or Optum Perks to save on prescriptions, you likely noticed a shift in your January...

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

My prescription costs what?! Pharmacists offer tips that could reduce your out-of-pocket drug costs

Even when Americans have health insurance, they can have a hard time affording the drugs they’ve been prescribed.

The Conversation

Prescription Discount Cards Are Being Restructured by Major Retailers

Prescription Discount Cards Are Being Restructured by Major Retailers

Prescription discount cards have long helped retirees reduce out-of-pocket medication costs. These cards, offered by companies like GoodRx, SingleCare, and Optum Perks, typically provide savings...

Get all your
news in one place.

100's of premium titles.
One news app.

GoodRx Stock Could Get a Major Trump Boost. Should You Buy It Here?

With a potential TrumpRx partnership, should investors buy GDRX stock now?

GoodRx CEO says successful leadership is about more than staying calm through chaos: It’s about bosses reclaiming control

The post‑pandemic pendulum swung too far in employees’ favor, warns GoodRx’s Wendy Barnes—and business leaders need to build resilient teams that execute under pressure.

Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch

Prescription savings platform GoodRx Holdings Inc. (NASDAQ:GDRX) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct discount programs.

A new era of access demands smarter design for direct-to-consumer drug pricing

A Fortune Most Powerful Women member, Barnes believes there are three essential elements for effective DTC models.

Get all your
news in one place.

100's of premium titles.
One news app.

Discounted Ozempic Could Deflate ETF Optimism Around Hims & Hers

Hims Hers Health Inc (NYSE:HIMS) investors can’t catch a break. Less than two months since Novo Nordisk AS (NYSE:NVO) terminated its Wegovy partnership with the telehealth company abruptly, the pharma giant is again in the news, this time partnering with GoodRx Holdings Inc (NASDAQ:GDRX) to provide discounted access to Ozempic…

What's Going On With Hims & Hers Shares Today?

Hims Hers Health Inc. (NYSE:HIMS) shares are trading lower Tuesday after GoodRx Inc. (NASDAQ:GDRX) announced a collaboration with Novo Nordisk to provide discounted access to two of the most in-demand GLP-1 drugs, Ozempic and Wegovy.

Ozempic Gains First Approval In Canada For Kidney Disease And Cardiovascular Death Risk

Health Canada on Tuesday approved Novo Nordisk's (NYSE:NVO) Ozempic (semaglutide) to reduce the risk of kidney disease and cardiovascular deaths in adults with type 2 diabetes.

GoodRx (GDRX) Stock Is Sliding Tuesday: What's Going On?

GoodRx Holdings Inc (NASDAQ:GDRX) shares are pulling back Tuesday morning, as investors potentially take profits following Monday’s surge. The stock had jumped over 30% Monday after the company announced a new partnership with Novo Nordisk to expand access to popular GLP-1 medications.

How GoodRx CEO Wendy Barnes is trying to halve the cost of GLP-1 obesity drugs

Also: All the news and watercooler chat from Fortune.

GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access

GoodRx Holdings Inc. (NASDAQ:GDRX) shares jumped 5.08% in after-hours trading on Monday, following the announcement of a collaboration with Novo Nordisk A/S (NYSE:NVO) to offer discounted GLP-1 medications at fixed pricing nationwide.

GoodRx Is Soaring on a Novo Nordisk Deal. Should You Buy GDRX Stock Here?

GoodRx stock soars after announcing GLP-1 partnership with Novo Nordisk. A Bank of America analyst recommends selling GDRX shares into the strength before they crash again.

1 2 3

People

211,699 stories

Tennessee Williams

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

the White House

The Independent

Bank of America

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Prescription Drug

Places

415,121 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play